Therapeutic Apheresis and Dialysis

Guest Editorial
pp. S1-S1(1)

Cinacalcet Treatment in Dialysis Patients with Secondary Hyperparathyroidism: Effects and Open Issues
pp. S2-S12(11)
Authors: Drüeke, Tilman B

Clinical Study of Cinacalcet in Japan
pp. S13-S15(3)
Authors: Akizawa, Tadao; Koshikawa, Shozo

Changes in Interventional Treatment—from the Viewpoint of Percutaneous Ethanol Injection Therapy
pp. S16-S20(5)
Author: Kitaoka, Masafumi

Parathyroidectomy for Secondary Hyperparathyroidism in the Era of Calcimimetics
pp. S21-S26(6)
Authors: Tominaga, Yoshihiro; Matsuoka, Susumu; Uno, Nobuaki; Sato, Tetsuhiko

Role of Cinacalcet in Management of Mineral Bone Disorder in Chronic Kidney Disease (Control of Calcium, Phosphorus and Parathyroid Hormone)
pp. S27-S33(7)
Author: Tahara, Hideki

Change in Coronary Artery Calcification Score due to Cinacalcet Hydrochloride Administration
pp. S34-S37(4)
Authors: Tsuruta, Yoshinari; Ohbayashi, Takaaki; Fujii, Mikiko; Myochin, Hisashi; Mizutani, Ryoko; Narita, Masayasu; Maeda, Kenji

Impact of Cinacalcet Hydrochloride on Bone Histology in Patients with Secondary Hyperparathyroidism
pp. S38-S43(6)
Authors: Yajima, Aiji; Akizawa, Tadao; Tsukamoto, Yusuke; Kurihara, Satoshi; Ito, Akemi

Impact of Cinacalcet Hydrochloride on the Achievement of the Japanese Society for Dialysis Therapy (JSDT) Guideline Targets: A post-hoc Analysis of the KRN1493 Study
pp. S44-S49(6)
Authors: Komaba, Hirotaka; Fukagawa, Masafumi